Amyloid β protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease

Akira Tamaoka, Naoya Sawamura, Tetsuo Fukushima, Shin'ichi Shoji, Etsuro Matsubara, Mikio Shoji, Shunsaku Hirai, Yoshiko Furiya, Riuko Endoh, Hiroshi Mori

Research output: Contribution to journalArticle

114 Citations (Scopus)

Abstract

To investigate the pathomechanism of amyloid β protein (Aβ) deposition in brains with Alzheimer's disease (AD), cerebrospinal fluid (CSF) levels of Aβ species (CSF-Aβ) with different carboxy termini, i.e. AβX-40 and AβX-42(43) as well as Aβ1-40 and Aβ1-42(43), were measured in patients with AD and age-matched controls without dementia (CTR) using sandwich enzyme-linked immunosorbent assays (ELISAs). The present study revealed that both CSF-AβX-42(43) and Aβ1-42(43) levels were significantly lower in the AD patients (P<0.005) than in the CTR group, whereas neither CSF-AβX-40 nor CSF-Aβ1-40 levels showed any differences between the two groups. In addition, although there was no difference between the ratios of AβX-40 to Aβ1-40 in the AD and CTR groups, the ratios of AβX-42(43)to Aβ1-42(43) were increased in the AD group compared with those in the CTR group (P<0.05). Therefore, it can be assumed that the ratios of amino terminal truncations and/or modifications of CSF-Aβ42(43) with carboxy termini ending at residue 42(43) were more increased in the AD group than in the CTR group. Increased adsorption of Aβ42(43) to Aβ deposition in AD brains, decreased secretion of Aβ42(43) to CSF and/or increased clearance of Aβ42(43) from CSF might explain the diminished levels of Aβ42(43) in the CSF of AD patients. In addition, CSF-Aβ42(43) could reflect increased amino terminal truncations and/or modifications of Aβ42(43) in AD brains.

Original languageEnglish
Pages (from-to)41-45
Number of pages5
JournalJournal of the Neurological Sciences
Volume148
Issue number1
DOIs
Publication statusPublished - 1997 May 1
Externally publishedYes

Fingerprint

Amyloidogenic Proteins
Cerebrospinal Fluid
Alzheimer Disease
Brain
Serum Amyloid A Protein
Adsorption
Dementia
Enzyme-Linked Immunosorbent Assay

Keywords

  • Alzheimer's disease
  • amyloid β protein
  • cerebrospinal fluid
  • enzyme-linked immunosorbent assay

ASJC Scopus subject areas

  • Ageing
  • Clinical Neurology
  • Surgery
  • Developmental Neuroscience
  • Neurology
  • Neuroscience(all)

Cite this

Amyloid β protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease. / Tamaoka, Akira; Sawamura, Naoya; Fukushima, Tetsuo; Shoji, Shin'ichi; Matsubara, Etsuro; Shoji, Mikio; Hirai, Shunsaku; Furiya, Yoshiko; Endoh, Riuko; Mori, Hiroshi.

In: Journal of the Neurological Sciences, Vol. 148, No. 1, 01.05.1997, p. 41-45.

Research output: Contribution to journalArticle

Tamaoka, A, Sawamura, N, Fukushima, T, Shoji, S, Matsubara, E, Shoji, M, Hirai, S, Furiya, Y, Endoh, R & Mori, H 1997, 'Amyloid β protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease', Journal of the Neurological Sciences, vol. 148, no. 1, pp. 41-45. https://doi.org/10.1016/S0022-510X(96)00314-0
Tamaoka, Akira ; Sawamura, Naoya ; Fukushima, Tetsuo ; Shoji, Shin'ichi ; Matsubara, Etsuro ; Shoji, Mikio ; Hirai, Shunsaku ; Furiya, Yoshiko ; Endoh, Riuko ; Mori, Hiroshi. / Amyloid β protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease. In: Journal of the Neurological Sciences. 1997 ; Vol. 148, No. 1. pp. 41-45.
@article{a74862622d7d4061935584cf91dc2817,
title = "Amyloid β protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease",
abstract = "To investigate the pathomechanism of amyloid β protein (Aβ) deposition in brains with Alzheimer's disease (AD), cerebrospinal fluid (CSF) levels of Aβ species (CSF-Aβ) with different carboxy termini, i.e. AβX-40 and AβX-42(43) as well as Aβ1-40 and Aβ1-42(43), were measured in patients with AD and age-matched controls without dementia (CTR) using sandwich enzyme-linked immunosorbent assays (ELISAs). The present study revealed that both CSF-AβX-42(43) and Aβ1-42(43) levels were significantly lower in the AD patients (P<0.005) than in the CTR group, whereas neither CSF-AβX-40 nor CSF-Aβ1-40 levels showed any differences between the two groups. In addition, although there was no difference between the ratios of AβX-40 to Aβ1-40 in the AD and CTR groups, the ratios of AβX-42(43)to Aβ1-42(43) were increased in the AD group compared with those in the CTR group (P<0.05). Therefore, it can be assumed that the ratios of amino terminal truncations and/or modifications of CSF-Aβ42(43) with carboxy termini ending at residue 42(43) were more increased in the AD group than in the CTR group. Increased adsorption of Aβ42(43) to Aβ deposition in AD brains, decreased secretion of Aβ42(43) to CSF and/or increased clearance of Aβ42(43) from CSF might explain the diminished levels of Aβ42(43) in the CSF of AD patients. In addition, CSF-Aβ42(43) could reflect increased amino terminal truncations and/or modifications of Aβ42(43) in AD brains.",
keywords = "Alzheimer's disease, amyloid β protein, cerebrospinal fluid, enzyme-linked immunosorbent assay",
author = "Akira Tamaoka and Naoya Sawamura and Tetsuo Fukushima and Shin'ichi Shoji and Etsuro Matsubara and Mikio Shoji and Shunsaku Hirai and Yoshiko Furiya and Riuko Endoh and Hiroshi Mori",
year = "1997",
month = "5",
day = "1",
doi = "10.1016/S0022-510X(96)00314-0",
language = "English",
volume = "148",
pages = "41--45",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Amyloid β protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease

AU - Tamaoka, Akira

AU - Sawamura, Naoya

AU - Fukushima, Tetsuo

AU - Shoji, Shin'ichi

AU - Matsubara, Etsuro

AU - Shoji, Mikio

AU - Hirai, Shunsaku

AU - Furiya, Yoshiko

AU - Endoh, Riuko

AU - Mori, Hiroshi

PY - 1997/5/1

Y1 - 1997/5/1

N2 - To investigate the pathomechanism of amyloid β protein (Aβ) deposition in brains with Alzheimer's disease (AD), cerebrospinal fluid (CSF) levels of Aβ species (CSF-Aβ) with different carboxy termini, i.e. AβX-40 and AβX-42(43) as well as Aβ1-40 and Aβ1-42(43), were measured in patients with AD and age-matched controls without dementia (CTR) using sandwich enzyme-linked immunosorbent assays (ELISAs). The present study revealed that both CSF-AβX-42(43) and Aβ1-42(43) levels were significantly lower in the AD patients (P<0.005) than in the CTR group, whereas neither CSF-AβX-40 nor CSF-Aβ1-40 levels showed any differences between the two groups. In addition, although there was no difference between the ratios of AβX-40 to Aβ1-40 in the AD and CTR groups, the ratios of AβX-42(43)to Aβ1-42(43) were increased in the AD group compared with those in the CTR group (P<0.05). Therefore, it can be assumed that the ratios of amino terminal truncations and/or modifications of CSF-Aβ42(43) with carboxy termini ending at residue 42(43) were more increased in the AD group than in the CTR group. Increased adsorption of Aβ42(43) to Aβ deposition in AD brains, decreased secretion of Aβ42(43) to CSF and/or increased clearance of Aβ42(43) from CSF might explain the diminished levels of Aβ42(43) in the CSF of AD patients. In addition, CSF-Aβ42(43) could reflect increased amino terminal truncations and/or modifications of Aβ42(43) in AD brains.

AB - To investigate the pathomechanism of amyloid β protein (Aβ) deposition in brains with Alzheimer's disease (AD), cerebrospinal fluid (CSF) levels of Aβ species (CSF-Aβ) with different carboxy termini, i.e. AβX-40 and AβX-42(43) as well as Aβ1-40 and Aβ1-42(43), were measured in patients with AD and age-matched controls without dementia (CTR) using sandwich enzyme-linked immunosorbent assays (ELISAs). The present study revealed that both CSF-AβX-42(43) and Aβ1-42(43) levels were significantly lower in the AD patients (P<0.005) than in the CTR group, whereas neither CSF-AβX-40 nor CSF-Aβ1-40 levels showed any differences between the two groups. In addition, although there was no difference between the ratios of AβX-40 to Aβ1-40 in the AD and CTR groups, the ratios of AβX-42(43)to Aβ1-42(43) were increased in the AD group compared with those in the CTR group (P<0.05). Therefore, it can be assumed that the ratios of amino terminal truncations and/or modifications of CSF-Aβ42(43) with carboxy termini ending at residue 42(43) were more increased in the AD group than in the CTR group. Increased adsorption of Aβ42(43) to Aβ deposition in AD brains, decreased secretion of Aβ42(43) to CSF and/or increased clearance of Aβ42(43) from CSF might explain the diminished levels of Aβ42(43) in the CSF of AD patients. In addition, CSF-Aβ42(43) could reflect increased amino terminal truncations and/or modifications of Aβ42(43) in AD brains.

KW - Alzheimer's disease

KW - amyloid β protein

KW - cerebrospinal fluid

KW - enzyme-linked immunosorbent assay

UR - http://www.scopus.com/inward/record.url?scp=0031149062&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031149062&partnerID=8YFLogxK

U2 - 10.1016/S0022-510X(96)00314-0

DO - 10.1016/S0022-510X(96)00314-0

M3 - Article

C2 - 9125389

AN - SCOPUS:0031149062

VL - 148

SP - 41

EP - 45

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 1

ER -